0 items USD 0.00Search
- Did you mean
- liposomal%storage%disease
Your search for "Lysosomal%2520Storage%2520Disease" gave back 355031 results.
The global Metabolic Disorder Therapeutics market is projected to reach US$ 64560 million in 2029, increasing from US$ 46680 million in 2022, with...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Metabolic Disorders Therapeutics is a drug used to treat the symptoms of metabolic disorders caused by a variety of causes. The “Metabolic Disorders...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Metabolic Disorder Therapeutics Industry Forecast” looks at past sales and reviews total world Metabolic Disorder Therapeutics sales in 2022,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,000.00
N Sulphoglucosamine Sulphohydrolase - Pipeline Review, H2 2020 Summary N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or...
Catalog:
Global Markets Direct
August 2020
Price: USD 3,500.00
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Metabolic Disorders Therapeutics is a drug used to treat the symptoms of metabolic disorders caused by a variety of causes. Highlights The global...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA...
Catalog:
Global Markets Direct
August 2022
Price: USD 3,500.00
Sandhoff Disease (Jatzkewitz-Pilz Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary...
Catalog:
Global Markets Direct
March 2022
Price: USD 2,000.00
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Lysosome Isolation Kit market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
June 2018
Price: USD 2,000.00
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
November 2021
Price: USD 2,000.00
AAV is transformed from a naturally occurring virus into a delivery mechanism for gene therapy. The viral DNA is replaced with new DNA, and it...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
